Human induced pluripotent stem cells derived from fetal neural stem cells successfully undergo directed differentiation into cartilage

Stem Cells and Development

Volumn 20, Issue 6, 2011, Pages 1099-1112

  Medvedev, Sergey P ^a,b   Grigor'Eva, Elena V ^a,b   Shevchenko, Alexander I ^a,b   Malakhova, Anastasia A ^a,b   Dementyeva, Elena V ^a,b   Shilov, Alexander A ^a   Pokushalov, Evgeny A ^c   Zaidman, Alla M ^d   Aleksandrova, Maria A ^e   Plotnikov, Egor Yu ^f   Sukhikh, Gennady T ^g   Zakian, Suren M ^a,b,h  

^a INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

^b INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

^c MESHALKIN NATIONAL MEDICAL RESEARCH CENTER   (Russian Federation)

^d NOVOSIBIRSK RESEARCH INSTITUTE OF TRAUMATOLOGY AND ORTHOPAEDICS N A YA L TSIVYAN   (Russian Federation)

^e KOL TSOV INSTITUTE OF DEVELOPMENTAL BIOLOGY   (Russian Federation)

^f MOSCOW STATE UNIVERSITY   (Russian Federation)

^g RESEARCH CENTER OF OBSTETRICS   (Russian Federation)

^h Research Institute of Experimental and Clinical Medicine   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

BIX 01294; CELL MARKER; KRUPPEL LIKE FACTOR 4; METHYLTRANSFERASE INHIBITOR; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; PLASMID VECTOR; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; VALPROIC ACID;

ANIMAL CELL; ARTICLE; CARTILAGE; CELL CLONE; CELL DIFFERENTIATION; CONTROLLED STUDY; ECTODERM; EMBRYONIC STEM CELL; ENDODERM; FETAL NEURAL STEM CELL; FETUS; FETUS CELL; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MESODERM; NEURAL STEM CELL; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL;

ALKALINE PHOSPHATASE; ANIMALS; BIOLOGICAL MARKERS; CARTILAGE; CELL COUNT; CELL DIFFERENTIATION; CELL SHAPE; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; FETAL STEM CELLS; GENE EXPRESSION REGULATION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; MICROSATELLITE REPEATS; NEURAL STEM CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC;

IPS;

EID: 79957868513     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2010.0249     Document Type: Article

References (49)

1. Takahashi K and S Yamanaka. (2006). Induction of plurip-otent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676. (Pubitemid 44233629)
2. Takahashi K, K Tanabe, M Ohnuki, M Narita, T Ichisaka, K Tomoda and S Yamanaka. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872. (Pubitemid 350138099)
3. Yu J, K Hu, K Smuga-Otto, S Tian, R Stewart, II Slukvin and JA Thomson. (2009). Human induced pluripotent stem cells free of vector and transgene sequences. Science 324:797-801.
4. Yu J, MA Vodyanik, K Smuga-Otto, J Antosiewicz-Bourget, JL Frane, S Tian, J Nie, GA Jonsdottir, V Ruotti, R Stewart, II Slukvin and JA Thomson. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.
5. Park IH, N Arora, H Huo, N Maherali, T Ahfeldt, A Shi-mamura, MW Lensch, C Cowan, K Hochedlinger and GQ Daley. (2008). Disease-specific induced pluripotent stem cells. Cell 134:877-886.
6. Karumbayaram S, BG Novitch, M Patterson, JA Umbach, L Richter, A Lindgren, AE Conway, AT Clark, SA Goldman, K Plath, M Wiedau-Pazos, HI Kornblum and WE Lowry. (2009). Directed differentiation of human-induced pluripo-tent stem cells generates active motor neurons. Stem Cells 27:806-811.
7. Chambers SM, CA Fasano, EP Papapetrou, M Tomishima, M Sadelain and L Studer. (2009). Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 27:275-280.
8. Carr AJ, AA Vugler, ST Hikita, JM Lawrence, C Gias, LL Chen, DE Buchholz, A Ahmado, M Semo, MJ Smart, S Hasan, L da Cruz, LV Johnson, DO Clegg and PJ Coffey. (2009). Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystro-phic rat. PLoS ONE 4:e8152.
9. Maehr R, S Chen, M Snitow, T Ludwig, L Yagasaki, R Go-land, RL Leibel and DA Melton. (2009). Generation of plu-ripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci USA 106:15768-15773.
10. Raya A, I Rodriguez-Piza, G Guenechea, R Vassena, S Navarro, MJ Barrero, A Consiglio, M Castella, P Rio, E Sleep, F Gonzalez, G Tiscornia, E Garreta, T Aasen, A Veiga, IM Verma, J Surralles, J Bueren and JC Izpisua Belmonte. (2009). Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 460:53-59.
11. Ebert AD, J Yu, FF Rose, Jr., VB Mattis, CL Lorson, JA Thomson and CN Svendsen. (2009). Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457:277-280.
12. Lee G, EP Papapetrou, H Kim, SM Chambers, MJ Tomishi-ma, CA Fasano, YM Ganat, J Menon, F Shimizu, A Viale, V Tabar, M Sadelain and L Studer. (2009). Modelling patho-genesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 461:402-406.
13. Okita K, T Ichisaka and S Yamanaka. (2007). Generation of germline-competent induced pluripotent stem cells. Nature 448:313-317. (Pubitemid 47080336)
14. Okita K, M Nakagawa, H Hyenjong, T Ichisaka and S Yamanaka. (2008). Generation of mouse induced pluripotent stem cells without viral vectors. Science 322:949-953.
15. Stadtfeld M, M Nagaya, J Utikal, G Weir and K Hoche-dlinger. (2008). Induced pluripotent stem cells generated without viral integration. Science 322:945-949.
16. Fusaki N, H Ban, A Nishiyama, K Saeki and M Hasegawa. (2009). Efficient induction of transgene-free human plurip-otent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci 85:348-362.
17. Nakagawa M, M Koyanagi, K Tanabe, K Takahashi, T Ichisaka, T Aoi, K Okita, Y Mochiduki, N Takizawa and S Yamanaka. (2008). Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26:101-106.
18. Wernig M, A Meissner, JP Cassady and R Jaenisch. (2008). c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2:10-12.
19. Kim JB, H Zaehres, G Wu, L Gentile, K Ko, V Sebastiano, MJ Arauzo-Bravo, D Ruau, DW Han, M Zenke and HR Scholer. (2008). Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 454: 646-650.
20. Kim JB, V Sebastiano, G Wu, MJ Arauzo-Bravo, P Sasse, L Gentile, K Ko, D Ruau, M Ehrich, D van den Boom, J Meyer, K Hubner, C Bernemann, C Ortmeier, M Zenke, BK Fleisch-mann, H Zaehres and HR Scholer. (2009). Oct4-induced pluripotency in adult neural stem cells. Cell 136:411-419.
21. Kim JB, B Greber, MJ Arauzo-Bravo, J Meyer, KI Park, H Zaehres and HR Scholer. (2009). Direct reprogramming of human neural stem cells by OCT4. Nature 461:649-653.
22. Kaji K, K Norrby, A Paca, M Mileikovsky, P Mohseni and K Woltjen. (2009). Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458: 771-775.
23. Shi Y, C Desponts, JT Do, HS Hahm, HR Scholer and S Ding. (2008). Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 3:568-574.
24. Shi Y, JT Do, C Desponts, HS Hahm, HR Scholer and S Ding. (2008). A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell 2:525-528. (Pubitemid 351729222)
25. Huangfu D, R Maehr, W Guo, A Eijkelenboom, M Snitow, AE Chen and DA Melton. (2008). Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol 26:795-797. (Pubitemid 351961456)
26. Huangfu D, K Osafune, R Maehr, W Guo, A Eijkelenboom, S Chen, W Muhlestein and DA Melton. (2008). Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 26:1269-1275.
27. Pain B, ME Clark, M Shen, H Nakazawa, M Sakurai, J Samarut and RJ Etches. (1996). Long-term in vitro culture and characterisation of avian embryonic stem cells with multiple morphogenetic potentialities. Development 122:2339-2348.
28. Kumaki Y, M Oda and M Okano. (2008). QUMA: quantification tool for methylation analysis. Nucleic Acids Res 36:W170-W175.
29. Medvedev SP, AI Shevchenko, EA Elisaphenko, TB Nester-ova, N Brockdorff and SM Zakian. (2008). Structure and expression pattern of Oct4 gene are conserved in vole Mi-crotus rossiaemeridionalis. BMC Genomics 9:162.
30. Mali P, Z Ye, HH Hommond, X Yu, J Lin, G Chen, J Zou and L Cheng. (2008). Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts. Stem Cells 26:1998-2005.
31. Loh YH, Q Wu, JL Chew, VB Vega, W Zhang, X Chen, G Bourque, J George, B Leong, J Liu, KY Wong, KW Sung, CW Lee, XD Zhao, KP Chiu, L Lipovich, VA Kuznetsov, P Robson, LW Stanton, CL Wei, Y Ruan, B Lim and HH Ng. (2006). The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 38:431-440.
32. Boyer LA, TI Lee, MF Cole, SE Johnstone, SS Levine, JP Zucker, MG Guenther, RM Kumar, HL Murray, RG Jenner, DK Gifford, DA Melton, R Jaenisch and RA Young. (2005). Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122:947-956. (Pubitemid 41345211)
33. Chan EM, S Ratanasirintrawoot, IH Park, PD Manos, YH Loh, H Huo, JD Miller, O Hartung, J Rho, TA Ince, GQ Daley and TM Schlaeger. (2009). Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat Biotechnol 27:1033-1037.
34. Cowan CA, I Klimanskaya, J McMahon, J Atienza, J Witmyer, JP Zucker, S Wang, CC Morton, AP McMahon, D Powers and DA Melton. (2004). Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med 350:1353-1356. (Pubitemid 38375373)
35. Adewumi O, B Aflatoonian, L Ahrlund-Richter, M Amit, PW Andrews, G Beighton, PA Bello, N Benvenisty, LS Berry, S Bevan, B Blum, J Brooking, KG Chen, AB Choo, GA Churchill, M Corbel, I Damjanov, JS Draper, P Dvorak, K Emanuelsson, RA Fleck, A Ford, K Gertow, M Gertsenstein, PJ Gokhale, RS Hamilton, A Hampl, LE Healy, O Hovatta, J Hyllner, MP Imreh, J Itskovitz-Eldor, J Jackson, JL Johnson, M Jones, K Kee, BL King, BB Knowles, M Lako, F Lebrin, BS Mallon, D Manning, Y Mayshar, RD McKay, AE Michalska, M Mikkola, M Mileikovsky, SL Minger, HD Moore, CL Mummery, A Nagy, N Nakatsuji, CM O'Brien, SK Oh, C Olsson, T Otonkoski, KY Park, R Passier, H Patel, M Patel, R Pedersen, MF Pera, MS Piekarczyk, RA Pera, BE Reubinoff, AJ Robins, J Rossant, P Rugg-Gunn, TC Schulz, H Semb, ES Sherrer, H Siemen, GN Stacey, M Stojkovic, H Suemori, J Szatkiewicz, T Turetsky, T Tuuri, S van den Brink, K Vintersten, S Vuoristo, D Ward, TA Weaver, LA Young and W Zhang. (2007). Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol 25:803-816. (Pubitemid 47052190)
36. Toh WS, EH Lee, M Richards and T Cao. (2010). In vitro derivation of chondrogenic cells from human embryonic stem cells. Methods Mol Biol 584:317-331.
37. Hwang NS, S Varghese, HJ Lee, Z Zhang, Z Ye, J Bae, L Cheng and J Elisseeff. (2008). In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells. Proc Natl Acad Sci USA 105:20641-20646.
38. Koay EJ, GM Hoben and KA Athanasiou. (2007). Tissue engineering with chondrogenically differentiated human embryonic stem cells. Stem Cells 25:2183-2190. (Pubitemid 47480476)
39. Yamanaka S. (2007). Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 1:39-49. (Pubitemid 46865811)
40. Park IH, R Zhao, JA West, A Yabuuchi, H Huo, TA Ince, PH Lerou, MW Lensch and GQ Daley. (2008). Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451:141-146.
41. Utikal J, N Maherali, W Kulalert and K Hochedlinger. (2009). Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells. J Cell Sci 122:3502-3510.
42. Sun N, NJ Panetta, DM Gupta, KD Wilson, A Lee, F Jia, S Hu, AM Cherry, RC Robbins, MT Longaker and JC Wu. (2009). Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci USA 106:15720-15725.
43. Aasen T, A Raya, MJ Barrero, E Garreta, A Consiglio, F Gonzalez, R Vassena, J Bilic, V Pekarik, G Tiscornia, M Edel, S Boue and JC Izpisua Belmonte. (2008). Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 26:1276-1284.
44. Buchholz DE, ST Hikita, TJ Rowland, AM Friedrich, CR Hinman, LV Johnson and DO Clegg. (2009). Derivation of functional retinal pigmented epithelium from induced plu-ripotent stem cells. Stem Cells 27:2427-2434.
45. Hirami Y, F Osakada, K Takahashi, K Okita, S Yamanaka, H Ikeda, N Yoshimura and M Takahashi. (2009). Generation of retinal cells from mouse and human induced pluripotent stem cells. Neurosci Lett 458:126-131.
46. Song Z, J Cai, Y Liu, D Zhao, J Yong, S Duo, X Song, Y Guo, Y Zhao, H Qin, X Yin, C Wu, J Che, S Lu, M Ding and H Deng. (2009). Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res 19: 1233-1242.
47. Gai H, EL Leung, PD Costantino, JR Aguila, DM Nguyen, LM Fink, DC Ward and Y Ma. (2009). Generation and characterization of functional cardiomyocytes using induced pluripotent stem cells derived from human fibroblasts. Cell Biol Int 33:1184-1193.
48. Tanaka T, S Tohyama, M Murata, F Nomura, T Kaneko, H Chen, F Hattori, T Egashira, T Seki, Y Ohno, U Koshimizu, S Yuasa, S Ogawa, S Yamanaka, K Yasuda and K Fukuda. (2009). In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes. Biochem Biophys Res Commun 385:497-502.
49. Tateishi K, J He, O Taranova, G Liang, AC D'Alessio and Y Zhang. (2008). Generation of insulin-secreting islet-like clusters from human skin fibroblasts. J Biol Chem 283:31601-31607